Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
4
×
deals
4
×
life sciences
national blog main
biotech
national top stories
clinical trials
crispr
gene editing
roche
san francisco blog main
abbvie
alexion pharmaceuticals
allergan
alnylam pharmaceuticals
alzheimer's disease
biopharma
boehringer ingelheim
cynthia collins
david walt
diagnostics
dicerna pharamceuticals
duchenne
editas medicine
europe blog main
europe top stories
fda
feng zhang
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
illumina
jennifer doudna
jim collins
leber congenital amaurosis type 10
licensing
m&a
mammoth biosciences
What
gene
4
×
medicines
editing
research
roche
abbvie
alliance
approval
betting
billion
bio
biopharma
biotech
caught
causing
create
crispr
deal
diagnostic
dicerna
disease
diseases
drug
duchenne
editas
exits
experimental
eye
fda
fix
genetic
heats
hepatitis
high
historic
human
intended
launches
medicine
pact
Language
unset
Current search:
gene
×
boston
×
" boston top stories "
×
deals
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
